Outlook Therapeutics, Inc.

Nasdaq:OTLK

Biological Products, (No Diagnostic Substances)·ISELIN, NJ

Governanceproxy statements · beneficial ownership

Proxy Statements

24 shown

Filed	Form	Description
1/26/26	DEFA14A	DEFA14A	→
1/26/26	DEF 14A	DEF 14A	→
2/10/25	DEF 14A	DEF 14A	→
1/31/25	PRE 14A	FORM PRE 14A	→
6/26/24	DEF 14A	DEF 14A	→
6/14/24	PRE 14A	PRE 14A	→
↓

Ownership Filings

40 shown

Filed	Form	Description
10/3/25	4	PRIMARY DOCUMENT	→
10/3/25	4	PRIMARY DOCUMENT	→
10/3/25	4	PRIMARY DOCUMENT	→
10/3/25	4	PRIMARY DOCUMENT	→
10/3/25	4	PRIMARY DOCUMENT	→
10/3/25	4	PRIMARY DOCUMENT	→
↓